The study results confirmed that patients receiving the Xeloda/cisplatin combination therapy lived at least as long without the cancer progressing as those treated with the current standard therapy.

• 该研究结果证实接受希罗达+顺铂联合疗法的患者至少可以与那些接受现时标准疗法的患者生存一样长的时间，而且癌症不恶化。